These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38467640)

  • 81. The matrix protein of Newcastle disease virus inhibits inflammatory response through IRAK4/TRAF6/TAK1/NF-κB signaling pathway.
    Duan Z; Xing J; Shi H; Wang Y; Zhao C
    Int J Biol Macromol; 2022 Oct; 218():295-309. PubMed ID: 35872314
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer.
    Li Y; Yang G; Zhang J; Tang P; Yang C; Wang G; Chen J; Liu J; Zhang L; Ouyang L
    J Med Chem; 2021 Aug; 64(16):12022-12048. PubMed ID: 34351741
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Glial Cells: Role of the Immune Response in Ischemic Stroke.
    Xu S; Lu J; Shao A; Zhang JH; Zhang J
    Front Immunol; 2020; 11():294. PubMed ID: 32174916
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A novel benzenediamine derivate rescued mice from experimental sepsis by attenuating proinflammatory mediators via IRAK4.
    Dou H; Song Y; Liu X; Yang L; Jiang N; Chen D; Li E; Tan R; Hou Y
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):191-200. PubMed ID: 24588661
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Interleukin-1 Receptor-Associated Kinase 1/4 as a Novel Target for Inhibiting Neointimal Formation After Carotid Balloon Injury.
    Bai S; Li D; Zhou Z; Cao J; Xu T; Zhang X; Wang Y; Guo J; Zhang Y
    J Atheroscler Thromb; 2015; 22(12):1317-37. PubMed ID: 26310493
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Structural dynamic analysis of apo and ATP-bound IRAK4 kinase.
    Gosu V; Choi S
    Sci Rep; 2014 Jul; 4():5748. PubMed ID: 25034608
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Deciphering the intrinsic dynamics of unphosphorylated IRAK4 kinase bound to type I and type II inhibitors.
    Gosu V; Sasidharan S; Saudagar P; Radhakrishnan K; Lee HK; Shin D
    Comput Biol Med; 2023 Jun; 160():106978. PubMed ID: 37172355
    [TBL] [Abstract][Full Text] [Related]  

  • 88. IRAK4 activity controls immune responses to intracellular bacteria Listeria monocytogenes and Mycobacterium smegmatis.
    Pattabiraman G; Murphy M; Agliano F; Karlinsey K; Medvedev AE
    J Leukoc Biol; 2018 Oct; 104(4):811-820. PubMed ID: 29749650
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model.
    Li GB; Ma S; Yang LL; Ji S; Fang Z; Zhang G; Wang LJ; Zhong JM; Xiong Y; Wang JH; Huang SZ; Li LL; Xiang R; Niu D; Chen YC; Yang SY
    J Med Chem; 2016 Sep; 59(18):8293-305. PubMed ID: 27535613
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Efficacy of Sishen Wan on dinitrobenzene sulfonic acid-induced ulcerative colitis and its effect on toll-like receptor 2/interleukin-1 receptor-associated kinase-4/nuclear factor-κB signal pathway.
    Zhaohua Z; Rong L; Nana DU; Xiangdong Z
    J Tradit Chin Med; 2022 Aug; 42(4):565-575. PubMed ID: 35848973
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Acanthoic acid protectsagainst ethanol-induced liver injury: Possible role of AMPK activation and IRAK4 inhibition.
    Yao YL; Han X; Song J; Zhang J; Li YM; Lian LH; Wu YL; Nan JX
    Toxicol Lett; 2017 Nov; 281():127-138. PubMed ID: 28964808
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation.
    Rekhter M; Staschke K; Estridge T; Rutherford P; Jackson N; Gifford-Moore D; Foxworthy P; Reidy C; Huang XD; Kalbfleisch M; Hui K; Kuo MS; Gilmour R; Vlahos CJ
    Biochem Biophys Res Commun; 2008 Mar; 367(3):642-8. PubMed ID: 18190779
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tolerogenic dendritic cells and TLR4/IRAK4/NF-κB signaling pathway in allergic rhinitis.
    Kang C; Li X; Liu P; Liu Y; Niu Y; Zeng X; Zhao H; Liu J; Qiu S
    Front Immunol; 2023; 14():1276512. PubMed ID: 37915574
    [TBL] [Abstract][Full Text] [Related]  

  • 94. MicroRNA-27a Negatively Modulates the Inflammatory Response in Lipopolysaccharide-Stimulated Microglia by Targeting TLR4 and IRAK4.
    Lv YN; Ou-Yang AJ; Fu LS
    Cell Mol Neurobiol; 2017 Mar; 37(2):195-210. PubMed ID: 26971344
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity.
    Abdelaziz AM; Diab S; Islam S; Basnet SKC; Noll B; Li P; Mekonnen LB; Lu J; Albrecht H; Milne RW; Gerber C; Yu M; Wang S
    Med Chem; 2019; 15(6):602-623. PubMed ID: 30569866
    [TBL] [Abstract][Full Text] [Related]  

  • 96. MicroRNA-544 inhibits inflammatory response and cell apoptosis after cerebral ischemia reperfusion by targeting IRAK4.
    Fang R; Zhao NN; Zeng KX; Wen Q; Xiao P; Luo X; Liu XW; Wang YL
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5605-5613. PubMed ID: 30229835
    [TBL] [Abstract][Full Text] [Related]  

  • 97. U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.
    Smith MA; Choudhary GS; Pellagatti A; Choi K; Bolanos LC; Bhagat TD; Gordon-Mitchell S; Von Ahrens D; Pradhan K; Steeples V; Kim S; Steidl U; Walter M; Fraser IDC; Kulkarni A; Salomonis N; Komurov K; Boultwood J; Verma A; Starczynowski DT
    Nat Cell Biol; 2019 May; 21(5):640-650. PubMed ID: 31011167
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of adenovirus-mediated knockdown of IRAK4 on synovitis in the osteoarthritis rabbit model.
    Li M; Li H; Ran X; Yin H; Luo X; Chen Z
    Arthritis Res Ther; 2021 Dec; 23(1):294. PubMed ID: 34863246
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Phosphorylation of Microglial IRF5 and IRF4 by IRAK4 Regulates Inflammatory Responses to Ischemia.
    Ngwa C; Mamun AA; Xu Y; Sharmeen R; Liu F
    Cells; 2021 Jan; 10(2):. PubMed ID: 33573200
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation
    Zhu H; Jian Z; Zhong Y; Ye Y; Zhang Y; Hu X; Pu B; Gu L; Xiong X
    Front Immunol; 2021; 12():714943. PubMed ID: 34367186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.